| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |